US Patent 7696172 Fibroblast growth factor-like polypeptides

Patent 7696172 was granted and assigned to Amgen on April, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

76961720

Patent Inventor Names

Arlen Thomason0

Benxian Liu0

Date of Patent

April 13, 2010

Patent Application Number

121636050

Date Filed

June 27, 2008

Patent Citations Received

‌

US Patent 12116413 Human antigen binding proteins that bind β-klotho, FGF receptors and complexes thereof

‌

US Patent 11840558 Methods of treating non-alcoholic steatohepatitis using FGF21 mutants

Patent Primary Examiner

‌

Christine J. Saoud

Patent abstract

The present invention provides Fibroblast Growth Factor-like (FGF-like) polypeptides, nucleic acid molecules encoding the same, and variants thereof.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7696172 Fibroblast growth factor-like polypeptides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API